|
1
|
Olokoba AB, Obateru OA and Olokoba LB:
Type 2 diabetes mellitus: A review of current trends. Oman Med J.
27:269–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Caspersen CJ, Thomas GD, Boseman LA,
Beckles GL and Albright AL: Aging, diabetes, and the public health
system in the United States. Am J Public Health. 102:1482–1497.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Gara PT, Kushner FG, Ascheim DD, Casey
DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM,
Franklin BA, et al: 2013 ACCF/AHA guideline for the management of
ST-elevation myocardial infarction: A report of the American
college of cardiology foundation/American heart association task
force on practice guidelines. Circulation. 127:e362–e425.
2013.PubMed/NCBI
|
|
4
|
Tong F, Luo L and Liu DJ: Effect of
intervention in mast cell function before reperfusion on renal
ischemia-reperfusion injury in rats. Kidney Blood Press Res.
41:335–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng W, Tang R, Ye X, Xue C and Liao Y:
Identification of genes and pathways associated with kidney
ischemia-reperfusion injury by bioinformatics analyses. Kidney
Blood Press Res. 41:48–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu T, Chen G, Tian F and Liu HX:
Contribution of cranial neural crest cells to mouse skull
development. Int J Dev Biol. 61:495–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shen X, Hu B, Xu G, Chen F, Ma R, Zhang N,
Liu J, Ma X, Zhu J, Wu Y and Shen R: Activation of Nrf2/HO-1
pathway by glycogen synthase kinase-3β inhibition attenuates renal
ischemia/reperfusion injury in diabetic rats. Kidney Blood Press
Res. 42:369–378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu B, Wu Y, Liu J, Shen X, Tong F, Xu G
and Shen R: GSK-3beta inhibitor induces expression of Nrf2/TrxR2
signaling pathway to protect against renal ischemia/reperfusion
injury in diabetic rats. Kidney Blood Press Res. 41:937–946. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Li B, Zheng Z, Kang T, Zeng M,
Liu Y and Xia B: Protective effects of Notch1 signaling activation
against high glucose-induced myocardial cell injury: Analysis of
its mechanisms of action. Int J Mol Med. 36:897–903. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koshizaka M, Takemoto M, Sato S, Tokuyama
H, Fujimoto M, Okabe E, Ishibashi R, Ishikawa T, Tsurutani Y,
Onishi S, et al: An angiotensin II type 1 receptor blocker prevents
renal injury via inhibition of the Notch pathway in Ins2 Akita
diabetic mice. Exp Diabetes Res. 2012:1598742012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonegio R and Susztak K: Notch signaling
in diabetic nephropathy. Exp Cell Res. 318:986–992. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Soni H, Matthews AT, Pallikkuth S,
Gangaraju R and Adebiyi A: γ-secretase inhibitor DAPT mitigates
cisplatin-induced acute kidney injury by suppressing Notch1
signaling. J Cell Mol Med. 23:260–270. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramos-Lobo AM, Buonfiglio DC and
Cipolla-Neto J: Streptozotocin-induced diabetes disrupts the body
temperature daily rhythm in rats. Diabetol Metab Syndr. 7:392015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Njomen GB, Kamgang R, Oyono JL and Njikam
N: Antioxidant potential of the methanol-methylene chloride extract
of Terminalia glaucescens leaves on mice liver in
streptozotocin-induced stress. Indian J Pharmacol. 40:266–270.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mus LM, Denecker G, Speleman F and Roman
BI: Vehicle development, pharmacokinetics and toxicity of the
anti-invasive agent 4-fluoro-3′,4′,5′-trimethoxychalcone in
rodents. PLoS One. 13:e01925482018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pearsall EA, Cheng R, Matsuzaki S, Zhou K,
Ding L, Ahn B, Kinter M, Humphries KM, Quiambao AB, Farjo RA and Ma
JX: Neuroprotective effects of PPARα in retinopathy of type 1
diabetes. PLoS One. 14:e02083992019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu B, Wu T, Zhao Y, Xu G, Shen R and Chen
G: Physiological signatures of dual embryonic origins in mouse
skull vault. Cell Physiol Biochem. 43:2525–2534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Furuya F, Ishii T and Kitamura K: Chronic
inflammation and progression of diabetic kidney disease. Contrib
Nephrol. 198:33–39. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garcia-Garcia PM, Getino-Melián MA,
Dominguez-Pimentel V and Navarro-González JF: Inflammation in
diabetic kidney disease. World J Diabetes. 5:431–443. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kazancioğlu R: Risk factors for chronic
kidney disease: An update. Kidney Int Suppl (2011). 3:368–371.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu W, Liang X and Yang D: The effects of
Chinese medicine on activation of Wnt/β-catenin signal pathway
under high glucose condition. Evid Based Complement Alternat Med.
2015:2951352015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cuzzocrea S, Mazzon E, Esposito E, Muià C,
Abdelrahman M, Di Paola R, Crisafulli C, Bramanti P and Thiemermann
C: Glycogen synthase kinase-3beta inhibition attenuates the
development of ischaemia/reperfusion injury of the gut. Intensive
Care Med. 33:880–893. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Collino M, Thiemermann C, Mastrocola R,
Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O,
Dianzani C, et al: Treatment with the glycogen synthase
kinase-3beta inhibitor, TDZD-8, affects transient cerebral
ischemia/reperfusion injury in the rat hippocampus. Shock.
30:299–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gui B, Hua F, Chen J, Xu Z, Sun H and Qian
Y: Protective effects of pretreatment with oleanolic acid in rats
in the acute phase of hepatic ischemia-reperfusion injury: Role of
the PI3K/Akt pathway. Mediators Inflamm. 2014:4518262014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niranjan T, Murea M and Susztak K: The
pathogenic role of Notch activation in podocytes. Nephron Exp
Nephrol. 111:e73–e79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin CL, Wang FS, Hsu YC, Chen CN, Tseng
MJ, Saleem MA, Chang PJ and Wang JY: Modulation of notch-1
signaling alleviates vascular endothelial growth factor-mediated
diabetic nephropathy. Diabetes. 59:1915–1925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Marquez-Exposito L, Cantero-Navarro E,
Lavoz C, Fierro-Fernández M, Poveda J, Rayego-Mateos S,
Rodrigues-Diez RR, Morgado-Pascual JL, Orejudo M, Mezzano S and
Ruiz-Ortega M: Could Notch signaling pathway be a potential
therapeutic option in renal diseases? Nefrologia. 38:466–475.
2018.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao L, Arany PR, Kim J, Rivera-Feliciano
J, Wang YS, He Z, Rask-Madsen C, King GL and Mooney DJ: Modulating
Notch signaling to enhance neovascularization and reperfusion in
diabetic mice. Biomaterials. 31:9048–9056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang C, Gao J, Wu B, Yan N, Li H, Ren Y,
Kan Y, Liang J, Jiao Y and Yu Y: Minocycline attenuates the
development of diabetic neuropathy by inhibiting spinal cord Notch
signaling in rat. Biomed Pharmacother. 94:380–385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Y, Zhang M, Wu Y, Jiang H, Fu H, Cai Y,
Xu Z, Liu C, Chen B and Yang T: Aberrant activation of Notch-1
signaling inhibits podocyte restoration after islet transplantation
in a rat model of diabetic nephropathy. Cell Death Dis. 9:9502018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Xiao W, Liu X, Zeng M, Luo L, Wu
M, Ye S and Liu Y: Blockade of Jagged/Notch pathway abrogates
transforming growth factor β2-induced epithelial-mesenchymal
transition in human retinal pigment epithelium cells. Curr Mol Med.
14:523–534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu L, Gao C, Chen G, Li X, Li J, Wan Q
and Xu Y: Notch signaling molecules activate TGF-β in rat mesangial
cells under high glucose conditions. J Diabetes Res.
2013:9797022013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu L, Li Z, Dong X, Xue X, Liu Y, Xu S,
Zhang J, Han J, Yang Y and Wang H: Polydatin protects diabetic
heart against ischemia-reperfusion injury via Notch1/Hes1-mediated
activation of Pten/Akt signaling. Oxid Med Cell Longev.
2018:27506952018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang R, Zhou Q, Veeraragoo P, Yu H and
Xiao Z: Notch2/Hes-1 pathway plays an important role in renal
ischemia and reperfusion injury-associated inflammation and
apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective
effect. Ren Fail. 33:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
